CARDLYTICS INC (CDLX) Stock Income Statement
NASDAQ:CDLX - Nasdaq - US14161W1053 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 272.59M | 278.30M | 309.20M | 298.50M | 267.10M | |||
| Cost Of Goods | 126.67M | 127.76M | 150.58M | 151.60M | 137.40M | |||
| Gross Profit | 145.92M | 150.54M | 158.63M | 147.00M | 129.70M | |||
| Operating Expenses | 206.26M | 214.28M | 225.54M | 148.10M | 226.10M | |||
| Research and Development | 48.27M | 49.61M | 51.35M | 51.90M | 37.80M | |||
| Selling, General, and Administrative Expenses | 137.82M | 138.77M | 146.48M | 182.90M | 154.20M | |||
| Operating Income | -60.34M | -63.74M | -66.92M | -1.20M | -96.40M | |||
| Interest Income/Expense | -4.58M | -6.82M | 968.00K | -8.90M | -13.80M | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | -113.39M | -118.74M | -68.75M | -456.60M | -26.20M | |||
| Income Before Taxes | -178.31M | -189.30M | -134.70M | -466.70M | -136.40M | |||
| Income Tax | N/A | 0.00 | 0.00 | -1.40M | -7.90M | |||
| Net Income | -178.31M | -189.30M | -134.70M | -465.30M | -128.60M | |||
| EBITDA | -32.34M | -35.87M | -37.40M | 36.34M | -66.53M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.55 | -3.91 | -3.69 | -13.92 | -3.99 | |||
| Non GAAP EPS | -0.51 | -0.39 | -0.34 | -1.82 | -1.21 | |||
| Statistics | ||||||||
| Gross Profit Margin | 53.53% | 54.09% | 51.30% | 49.25% | 48.56% | |||
| Profit Margin | -65.41% | -68.02% | -43.56% | -155.88% | -48.15% | |||
| Operating Profit Margin | -22.14% | -22.90% | -21.64% | -0.40% | -36.09% | |||
All data in USD